CD4 and type 2 diabetes mellitus: Within the BNT162b2-elicited S-reactive CD4+T cells, the proportions of CM and EM cells were largely comparable between HCs and participants with type 2 diabetes following both doses of vaccination (Figures 4D, E; Supplementary Figure 8C).